Lieff Cabraser attorney Edward Baker will be featured as a distinguished speaker at Blue Cross Blue Shield’s 2023 Law, Audit, Compliance & Ethics Conference taking place August 6–9, 2023 in Austin, Texas, where he will co-lead a panel discussion entitled “Before the Subpoena Arrives: Proactive Strategies for Payers and Providers to Get Ahead of Medicare Advantage Compliance Problems.” The panel will incorporate defense, government enforcement, and relator bar perspectives, address common payor and provider compliance problems related to Medicare Advantage plans, and discuss how to prevent these problems from escalating into higher risk audit and compliance issues or full-blown False Claims Act government investigations.
About Edward Baker
Edward Baker is Of Counsel at Lieff Cabraser Heimann & Bernstein, LLP. He previously served as an Assistant U.S. Attorney in the Eastern District of California, where he was the Civil Healthcare Fraud Coordinator, as well as the Elder Justice Coordinator, within the Affirmative Civil Enforcement practice group. As an AUSA, Mr. Baker investigated numerous FCA cases, including allegations against physicians for medically unnecessary procedures, pharmacies for kickbacks to nursing homes, defense contractors and federal grant recipients for fraudulent billing, and hospitals for up-coding. He was the lead attorney for the United States in an FCA settlement against a group of Fresno cardiologists for performing medically unnecessary nuclear scans, and in a qui tam settlement against Omnicare, Inc., a national long-term care pharmacy, for improperly submitting claims for prescription drugs dispensed to patients in skilled nursing facilities. He worked closely with criminal prosecutors to enhance the district’s parallel proceedings practice and coordinated regular meetings of the EDCA Healthcare Fraud Task Force.
Prior to serving as an AUSA, Mr. Baker was an Assistant Attorney General for the State of Vermont, where he was the Director of the Medicaid Fraud and Residential Abuse Unit. He was a member of the litigation table team for thirty-six states in a qui tam lawsuit against Wyeth and Pfizer for Medicaid pharmaceutical “best price” violations that ultimately resulted in a $785 million settlement. He also laid the groundwork for the enactment of the Vermont False Claims Act and held leadership positions within the National Association of Medicaid Fraud Control Units.